AKT1 and neoplasm: One case of heterogeneity is due the up regulation in endothelial cells, associated with tumours, of the PI3K/AKT pathway which has been reported in some intra tumour endothelial cells[72], one of the consequences is the variable response to angiogenic factors like VEGF and to their blockage[73].